BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37358932)

  • 1. Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time-Temperature Transformation.
    Lalge R; Kumar NSK; Suryanarayanan R
    Mol Pharm; 2023 Aug; 20(8):4196-4209. PubMed ID: 37358932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Drug-Polymer Interactions on Time-Temperature-Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions.
    Lalge R; Kumar NSK; Suryanarayanan R
    Mol Pharm; 2023 Mar; 20(3):1806-1817. PubMed ID: 36744878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
    Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
    Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S; Sharma J; Munjal B; Bansal AK
    Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
    Rumondor AC; Stanford LA; Taylor LS
    Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.
    Butreddy A; Sarabu S; Almutairi M; Ajjarapu S; Kolimi P; Bandari S; Repka MA
    Int J Pharm; 2022 Mar; 615():121471. PubMed ID: 35041915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Correlation between Miscibility and Physical Stability of Amorphous Solid Dispersions Using Fluorescence-Based Techniques.
    Tian B; Tang X; Taylor LS
    Mol Pharm; 2016 Nov; 13(11):3988-4000. PubMed ID: 27700109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.
    Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
    Mol Pharm; 2014 Nov; 11(11):4228-37. PubMed ID: 25325389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
    Konno H; Taylor LS
    Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S; Lee TWY; Chow AHL
    Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Variability of Physical Properties of Povidone K30 on Crystallization and Drug-Polymer Miscibility of Celecoxib-Povidone K30 Amorphous Solid Dispersions.
    Phadke C; Sharma J; Sharma K; Bansal AK
    Mol Pharm; 2019 Oct; 16(10):4139-4148. PubMed ID: 31454247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.